bisoprolol has been researched along with Innate Inflammatory Response in 1 studies
Bisoprolol: A cardioselective beta-1 adrenergic blocker. It is effective in the management of HYPERTENSION and ANGINA PECTORIS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nishio, M | 1 |
| Sakata, Y | 1 |
| Mano, T | 1 |
| Ohtani, T | 1 |
| Takeda, Y | 1 |
| Miwa, T | 1 |
| Hori, M | 1 |
| Masuyama, T | 1 |
| Kondo, T | 1 |
| Yamamoto, K | 1 |
1 other study available for bisoprolol and Innate Inflammatory Response
| Article | Year |
|---|---|
Beneficial effects of bisoprolol on the survival of hypertensive diastolic heart failure model rats.
Topics: Adrenergic beta-Antagonists; Animals; Bisoprolol; Disease Models, Animal; Dose-Response Relationship | 2008 |